HighVista Strategies’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

HighVista Strategies’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,300	Closed	-$119K	–	145
2020 Q4	$119K	Hold	10,300	–	–	0.08%	80
2020 Q3	$78K	Hold	10,300	–	–	0.06%	93
2020 Q2	$68K	Hold	10,300	–	–	0.06%	88
2020 Q1	$53K	Hold	10,300	–	–	0.05%	42
2019 Q4	$79K	Hold	10,300	–	–	0.06%	98
2019 Q3	$55K	Buy	+10,300	New	+$63.9K	0.04%	116

Other funds holding CDMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HighVista Strategies's CDMO Position: Q1 2021 in Review

HighVista Strategies sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2021, closing a stake of 10,300 shares — an estimated $119K sold.

HighVista Strategies first reported a position in CDMO in Q3 2019 and held it in 6 quarters. The position peaked at $119K in Q4 2020. 158 funds tracked by Wall St. Rank hold CDMO as of Q1 2021.

HighVista Strategies reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
HighVista Strategies sold 10,300 Avid Bioservices, Inc. Common Stock shares in Q1 2021, an estimated $119K.
HighVista Strategies first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
HighVista Strategies's Avid Bioservices, Inc. Common Stock position peaked at $119K in Q4 2020.
158 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2021.

Based on HighVista Strategies's 13F filing for Q1 2021, filed 17 May 2021.